Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi/Regeneron Choose Access Over Price With Dupixent Launch

Mar 28 2017

• By Jessica Merrill

Dupixenst injection box and syringe

Related Content

ICER Atopic Dermatitis Review Prompted By First Biologic

Oct 20 2016

Atopic Dermatitis Market Snapshot: The Next Multi-Billion Dollar Opportunity

Oct 20 2016

'Transformative' Dupilumab Set For Third Quarter Filing In Atopic Dermatitis

Apr 01 2016

Pfizer’s Eucrisa Approval By FDA Adds New Dermatology Anchor

Dec 14 2016

Pressed Sanofi CEO Hopes For Positive Dupixent Launch, Praluent Ruling

Feb 08 2017

Related Companies

Sanofi

Regeneron Pharmaceuticals, Inc.

AbbVie Inc.

Johnson & Johnson

Express Scripts Holding Company

Pfizer Inc.

Astellas Pharma, Inc.

Bausch Health Companies Inc.

Amgen, Inc.

Additional Topics

Launches Approvals Pricing Strategies Commercial Dermatology BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window